| . | MMP/RSL Pathology Sites (n = 21) (%) . | MWL Pathology Sites (n = 36) (%) . | P-value . |
|---|---|---|---|
| Pathology prior to localizationa | - | - | 0.364 |
| Malignant | 5 (23.8) | 11 (30.6) | - |
| Benign | 1 (4.76) | 8 (22.2) | - |
| Postsurgical pathology | - | - | 0.772 |
| Malignant | 15 (71.4) | 23 (63.9) | - |
| Benign | 6 (28.6) | 13 (36.1) | - |
| Re-excision | 2 (9.5) | 6 (16.7) | - |
| Concordanceb | 21 (100) | 36 (100) | - |
| . | MMP/RSL Pathology Sites (n = 21) (%) . | MWL Pathology Sites (n = 36) (%) . | P-value . |
|---|---|---|---|
| Pathology prior to localizationa | - | - | 0.364 |
| Malignant | 5 (23.8) | 11 (30.6) | - |
| Benign | 1 (4.76) | 8 (22.2) | - |
| Postsurgical pathology | - | - | 0.772 |
| Malignant | 15 (71.4) | 23 (63.9) | - |
| Benign | 6 (28.6) | 13 (36.1) | - |
| Re-excision | 2 (9.5) | 6 (16.7) | - |
| Concordanceb | 21 (100) | 36 (100) | - |
Abbreviations: MMP, MRI-guided marker placement; MWL, mammographic-guided wire localization; RSL, radioactive seed localization.
aNot all patients had pathology available prior to localization.
bAll patients with bracketing who underwent a single lumpectomy were reported as one pathology site, and two patients in the MWL group were reported with two pathology sites, for a total of 36 final pathology results.
| . | MMP/RSL Pathology Sites (n = 21) (%) . | MWL Pathology Sites (n = 36) (%) . | P-value . |
|---|---|---|---|
| Pathology prior to localizationa | - | - | 0.364 |
| Malignant | 5 (23.8) | 11 (30.6) | - |
| Benign | 1 (4.76) | 8 (22.2) | - |
| Postsurgical pathology | - | - | 0.772 |
| Malignant | 15 (71.4) | 23 (63.9) | - |
| Benign | 6 (28.6) | 13 (36.1) | - |
| Re-excision | 2 (9.5) | 6 (16.7) | - |
| Concordanceb | 21 (100) | 36 (100) | - |
| . | MMP/RSL Pathology Sites (n = 21) (%) . | MWL Pathology Sites (n = 36) (%) . | P-value . |
|---|---|---|---|
| Pathology prior to localizationa | - | - | 0.364 |
| Malignant | 5 (23.8) | 11 (30.6) | - |
| Benign | 1 (4.76) | 8 (22.2) | - |
| Postsurgical pathology | - | - | 0.772 |
| Malignant | 15 (71.4) | 23 (63.9) | - |
| Benign | 6 (28.6) | 13 (36.1) | - |
| Re-excision | 2 (9.5) | 6 (16.7) | - |
| Concordanceb | 21 (100) | 36 (100) | - |
Abbreviations: MMP, MRI-guided marker placement; MWL, mammographic-guided wire localization; RSL, radioactive seed localization.
aNot all patients had pathology available prior to localization.
bAll patients with bracketing who underwent a single lumpectomy were reported as one pathology site, and two patients in the MWL group were reported with two pathology sites, for a total of 36 final pathology results.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
